Yu jiren
Yu jiren
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma | gastric adenocarcinoma | Active, not recruiting | Phase 2 | 2026-09-09 | NCT05715931 | |
| Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05) | gastric adenocarcinoma | Recruiting | Phase 2 | 2024-01-17 | NCT05872685 | |
| Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma | Epstein-Barr virus-associated gastric carcinoma, gastric adenocarcinoma | Not yet recruiting | Phase 2 | 2023-08-01 | NCT05970627 | |
| Perioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma | gastric adenocarcinoma, mismatch repair cancer syndrome 1 | Recruiting | Phase 2 | 2023-07-25 | NCT05729646 |